N-[(9-Ethylcarbazol-3-yl)methylene]-2-methyl-1-indolinylamine>98.0%(HPLC)1g

(4S,4'S)-2,2'-(1,3-BIS(4-(TERT-BUTYL)PHENYL)PROPANE-2,2-DIYL)BIS(4-ISOPROPYL-4,5-DIHYDROOXAZOLE), 95%, 1g

N-CYCLOPROPYLOXETAN-3-AMINE, 95.0%, 250mg

5-METHOXY-6-NITRO-2,3-DIHYDRO-1H-INDOLE, 95.0%, 250mg

3,4-Dimethylhippuric Acid>98.0%(T)(HPLC)200mg

Lithium Formate Monohydrate>98.0%(T)25g

(4R)-4-Isopropyl-1-methyl-7-oxabicyclo[4.1.0]heptane, 95.0%, 25g

1-(chloromethyl)-4-methyl-2,6,7-trioxabicyclo[2.2.2]octane, 95.0%, 250mg

4-ethoxy-2-hydrazinyl-6-methylpyrimidine, 95.0%, 500mg

4-(Toluene-4-sulfonyloxy)-piperidine-1-carboxylic acid tert-butyl ester, 96.0%, 10g

Methyl 2-amino-3-methoxybenzoate, 95.0%, 1g

(Toluene-4-sulfonyloxy)-acetic acid ethyl ester, 95.0%, 5g

H-Tyr(tBu)-Ome HCl, 95.0%, 250mg